Biotech industry veteran with two decades of clinical development, manufacturing, and technical operations leadership to guide ImmunoScape's "Seed and Boost" platform...
Apr 25, 2026
ImmunoScape presented new preclinical data at the AACR Annual Meeting 2026, highlighting the potential of its Seed and Boost™ platform in solid tumor immunotherapy. Key...
Mar 4, 2026
ImmunoScape Announces Memorandum of Understanding for Clinical Trial with Premier U.S. Cancer Center
The company also announced a strategic investment from Leonardo DiCaprio SINGAPORE and SAN DIEGO-- ImmunoScape Pte. Ltd., an A*STAR spin-out backed by Amgen Ventures...
Nov 13, 2025
“Seed-and-Boost” Approach with Breakthrough Potential, Poised to Transform the Cancer Immunotherapy Landscape SINGAPORE -- ImmunoScape Pte. Ltd., an A*STAR spin out...
Nov 4, 2025
Exclusive collaboration and license agreement focuses on advancing novel, T cell therapy “Seed-and-Boost” approach exploiting the mechanism of the CUE-100 series of...